Single center clinical study on the effect of active screening of carbapenem resistant Enterobacteriaceae bacteria on nosocomial infection prevention and control of hospitalized children in PICU

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000037694

Enrollment

Unknown

Registered

2020-08-30

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nosocomial infection

Interventions

control group:routine pathogenic microorganism method

experimental group:routine pathogenic microorganism method combined with active screening

Eligibility

Sex/Gender

All

Age

No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1. 28 days < age < 18 years old patients; 1. Patients who have been admitted to ICU within 1 month; 3. Patients with history of carbapenem use in recent 3 months; 4. Patients with a history of surgery within 1 month; 5. Those who had invasive operation within one month; 6. Patients transferred from other hospitals; 7. Patients with long-term use of immunosuppressants; 8. Patients with a history of mechanical ventilation within 1 month.

Exclusion criteria

Exclusion criteria: 1. Patients who did not take the first anal swab screening sampling within 24 hours after admission to PICU; 2. Patients with incomplete clinical data; 3. Patients with hospitalization time < 48h.

Design outcomes

Primary

Measure	Time frame
CRE infection rate;	—

Countries

China

Contacts

Public ContactYan Gangfeng

Pediatric Hospital affiliated to Fudan University

jinyi036@126.com+86 15900603082

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026